Stocks That Hit 52-Week Lows On Tuesday
During Tuesday, 581 stocks hit new 52-week lows.
Interesting Highlights From Today's 52-Week Lows
Meta Platforms (NASDAQ:FB) was the biggest company on a market cap basis to set a new 52-week low.
Nabriva Therapeutics’s Return On Capital Employed Overview
Nabriva Therapeutics (NASDAQ:NBRV) brought in sales totaling $9.26 million during Q4 according to data provided by Benzinga Pro. However, earnings decreased 22.63%, resulting in a loss of $13.06 million.
Nabriva Therapeutics Q4 EPS $(0.24) Misses $(0.19) Estimate, Sales $9.30M Miss $10.10M Estimate
Nabriva Therapeutics (NASDAQ:NBRV) reported quarterly losses of $(0.24) per share which missed the analyst consensus estimate of $(0.19) by 26.32 percent. This is a 78.38 percent increase over losses of $(1.11) per share
Earnings Scheduled For March 29, 2022
Companies Reporting Before The Bell
• 36KR Holdings (NASDAQ:KRKR) is projected to report quarterly loss at $0.02 per share on revenue of $15.62 million.
The Week Ahead In Biotech (March 27-April 2): Lipocine, Akebia, Merck Await FDA Verdicts, Adcom Test For Amylyx, BioNTech Earnings And More
Biotech stocks reversed course in the week ending March 25, as an increase in risk appetite prompted traders to move money out of defensives and into risky bets.
Stocks That Hit 52-Week Lows On Tuesday
During Tuesday's trading, 98 companies set new 52-week lows.
‘Study to Assess the Safety and PK of Oral and IV Xenleta in Adults With Cystic Fibrosis’ – ClinicalTrials.gov
https://clinicaltrials.gov/ct2/show/NCT05225805
63 Biggest Movers From Yesterday
Gainers
Kiora Pharmaceuticals, Inc. (NASDAQ: KPRX) shares surged 93.2% to close at $1.70 on Thursday. Kiora Pharmaceuticals recently appointed David Hollander, MD, MBA, to its Board of Directors.